Skip to main content
SpringerLink
Log in

Radioiodine and thyroid-associated ophtalmopahty: From the myth to the reality

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chiovato L., Rocchi R., Fiore E. Radioiodine is an effective, inexpensive and safe treatment for Graves’ hyperthroidism, but its immunological effects must be taken into account. J. Endocrinol. Invest. 1999, 22: 310–312.

    Article  CAS  PubMed  Google Scholar 

  2. De Groot L.J., Gorman C.A., Pinchera A., Bartalena L., Marocci C., Wiersinga W.M., Prummel M.F., Wartofsky L. Therapeutic controversies. Radiation and Graves’ ophtalmopathy. J. Clin. Endocrinol. Metab. 1995, 80: 339.

    Google Scholar 

  3. Bartalena L., Marocci C., Bogazzi F., Manetti L., Tanda M.L., Deell’Uno E., Bruno-Bossi G., Nardi M., Bartolomei M.P., Lepri A., Rossi G., Martino E., Pinchera A. Relation between therapy for hyperthyroidism and the course of Graves’ ophtalmopathy. N. Engl. J. Med. 1998, 338: 73.

    Article  CAS  PubMed  Google Scholar 

  4. Chiovato L., Fiore E., Vitti P., Rocchi R., Rago T., Dokic D., Latrofa F., Mammoli C., Lippi F., Ceccarelli C., Pinchera A. Outcome of thyroid function in Graves’ disease treated with radioiodine: role of thyroid stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J. Clin. Endocrinol. Metab. 1998, 83: 40.

    CAS  PubMed  Google Scholar 

  5. Bartalena L., Marcocci C., Pinchera A. Treating severe Graves’ ophthalmopathy. Baillère’s Clin. Endocrinol. Metab. 1997, 11: 521.

    Article  CAS  Google Scholar 

  6. Tallstedt L., Lundell G., Torring O., Wallin G., Ljunggren J.-G., Blomberg H., Taube A. and the Thyroid Study Group. Occurrence of ophtalmopathy after treatment for Graves’hyperthyroidism. N. Engl. J. Med. 1992, 326: 1733.

    Article  CAS  PubMed  Google Scholar 

  7. Gorman C.A. Radioiodine therapy does not aggravate Graves’ ophtalmopathy. J. Clin. Endocrinol. Metab. 1995, 80: 340.

    Article  CAS  PubMed  Google Scholar 

  8. Perros P., Crombie A., Matthews J., Kendall-Taylor P. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combine thyroid-eye clinic. Clin. Endocrinol. (Oxf.) 1993, 38: 367.

    Article  CAS  Google Scholar 

  9. Marcocci C., Bartalena L., Bogazzi F., Bruno-Bossio G., Pinchera A. Relationship between Graves’ ophtalmopathy and type of treatment of Graves’ hyperthyroidism. Thyroid, 1992, 2: 171.

    Article  CAS  PubMed  Google Scholar 

  10. Abe Y., Sato H., Noguchi M., Mimura T., Sugino K., Ozaki O., Yoshimura H., Ito K. Effect of subtotal thyroidectomy on natural history of ophtalmopathy in Graves’ disease. World J. Surg. 1998, 22: 714.

    Article  CAS  PubMed  Google Scholar 

  11. Catz B., Perzik S.L. Total thyroidectomy in the management of thyrotoxic and euthyroid Graves’ disease. Am. J. Med. 1989, 87: 70.

    Article  Google Scholar 

  12. Gunji K., Kubota S., Swanson J., Kiljanski I., Bernardzuk T., Vangrowicz S., Solvi M., Kall J.R. Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens. Thyroid 1998, 8: 553.

    Article  CAS  PubMed  Google Scholar 

  13. Burmeister L.A., Beatty R.L., Wall J.R. Malignant ophtalmopathy presenting one week after radioiodine treatment of hyperthyroidism. Thyroid 9: 189, 1999.

    Article  CAS  PubMed  Google Scholar 

  14. Feldt-Rasmussen U., Schleusener H., Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy for Graves’ disease. J. Clin. Endocrinol. Metab. 1994, 78: 98.

    CAS  PubMed  Google Scholar 

  15. Heufelder A.E. Retro-orbital autoimmunity. Baillière’s Clin. Endocrinol. Metab., 1997, 11: 521.

    Article  Google Scholar 

  16. Mc Gregor A.M. Has the target autoantigen for Graves’ ophtalmopathy been found? Lancet 1998, 352: 595.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de Médecine Nucléaire, University of Louvain Medical School, UCL 54.30, Av. hipocrate, 54, B-1200, Brussels, Belgium

    C. Beckers MD

Authors
  1. C. Beckers MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beckers, C. Radioiodine and thyroid-associated ophtalmopahty: From the myth to the reality. J Endocrinol Invest 22, 705–707 (1999). https://doi.org/10.1007/BF03343634

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343634

Key-words

Search

Navigation